142 results
Page 2 of 8
8-K
EX-99.1
f8jkf151
14 Nov 23
ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
4:02pm
8-K
EX-99.2
t46ra6vxi5ry85nbfss
14 Aug 23
ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update
4:13pm
8-K
EX-99.1
3jb6p1sgf3a5lmlucx1
14 Aug 23
ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update
4:13pm
8-K
EX-99.1
ivaklouuw0ytt6
6 Jul 23
ENDRA Life Sciences Announces Adjournment of
5:25pm
DEFA14A
EX-99.1
bk57odv8n 89f6jqgdc
6 Jul 23
Additional proxy soliciting materials
5:25pm
8-K
EX-99.1
2o1gaqswp6a ribs4u
15 May 23
ENDRA Life Sciences Reports First Quarter 2023 Financial Results and Provides a Business Update
12:00am
8-K
EX-99.2
9f1 7af6gqw
2 May 23
ENDRA Life Sciences Announces Pricing of Upsized $4.5 Million Public Offering
4:16pm
8-K
EX-99.1
7jw3p xfdpsidgp
2 May 23
ENDRA Life Sciences Announces Pricing of Upsized $4.5 Million Public Offering
4:16pm
424B5
fy0voeag69w8e 4ui
28 Apr 23
Prospectus supplement for primary offering
4:51pm
8-K
EX-99.1
22iqxc 5j4o
14 Nov 22
ENDRA Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update
4:32pm